Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma with high mutation burdens but a low response rate to immune checkpoint inhibitors. In this study, we performed targeted next-generation sequencing and fluorescent multiplex immunohistochemistry, and investigated the clinical...

詳細記述

保存先:
書誌詳細
出版年:Oncoimmunology
主要な著者: You, Hua, Xu-Monette, Zijun Y., Wei, Li, Nunns, Harry, Nagy, Máté L., Bhagat, Govind, Fang, Xiaosheng, Zhu, Feng, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Benjamin M., Van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Li, Yong, Au, Qingyan, Xu, Bing, Albitar, Maher, Young, Ken H.
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8293967/
https://ncbi.nlm.nih.gov/pubmed/34350060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1928365
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料